Ace
13 Views
Abbott Laboratories, maker of BinaxNOW, is set to receive more than half the government’s total outlay on rapid COVID screening, with some $2.2 billion in commitments while iHealth Labs secured a $1.3 billion deal to provide test for Biden’s free-at home testing program.
This post was created with our nice and easy submission form. Create your post!
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%
AcceptHere you'll find all collections you've created before.
Comments
Loading…